For example, the drug Liraglutide (Victoza)—a glucagon-like peptide-1 receptor (GLP-1R) agonist—is approved for the treatment of T2D and is a top-selling drug produced by Novo Nordisk [10]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.